ARTICLE | Clinical News
Antineoplastons regulatory update
January 19, 2009 8:00 AM UTC
Burzynski Research received an SPA from FDA for a Phase III trial to evaluate antineoplaston in combination with radiotherapy to treat newly-diagnosed diffuse intrinsic brainstem glioma in pediatric p...